Profile data is unavailable for this security.
About the company
Sprint Bioscience AB is a Sweden-based drug development company. It is engaged in the development of oncology therapeutics, focusing on cancer metabolism and liquid signaling. The Company's research is based on its fragment based drug discovery (FBDD) platform, which enables rapid indentifying of molecules with properties suitable for drug development. Its pipeline is divided in two research areas: cancer metabolism and autophagy, comprising products in the phases of establishing FBDD project and in the in vivo development. The Company’s strategy involves out-licensing or collaborating at an early stage of drug discovery in order to focus on current market needs.
- Revenue in SEK (TTM)85.01m
- Net income in SEK14.72m
- Incorporated2009
- Employees36.00
- LocationSprint Bioscience ABNovum, Halsovagen 7, Floor 8, elevator AHUDDINGE 141 57SwedenSWE
- Phone+46 84114455
- Websitehttps://www.sprintbioscience.com/
More ▼